02.12.2021 - – Preclinical data demonstrate sotrovimab, authorized in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron – – Data to be confirmed by further in vitro pseudo-virus .
This World AIDS Day, as part of the HIV in View campaign, ViiV Healthcare releases survey data highlighting outdated attitudes and beliefs about HIV, despite advances in treatment and care Pervasive